Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO) Insider Trading
Directors, officers and holders of more than 10% of AGIO report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 365 transactions on file: 0 with code P, 5 with code S and 45 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | 7,866 | $37.69 | $296,470 |
| Oct 26, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 7,866 | $25.01 | $196,729 |
| Oct 26, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 7,866 | Not measured | Not measured |
| Oct 22, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 500 | $25.01 | $12,505 |
| Oct 22, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | 500 | $37.52 | $18,760 |
| Oct 22, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 500 | Not measured | Not measured |
| Oct 21, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | 1,489 | $37.53 | $55,882 |
| Oct 21, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 1,489 | $25.01 | $37,240 |
| Oct 21, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 1,489 | Not measured | Not measured |
| Aug 4, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | 30,000 | $30.48 | $914,400 |
| Jul 8, 2026 | Backstrom Jay T. | Director | A Award | 1,447 | Not measured | Not measured |
| Jul 8, 2026 | Backstrom Jay T. | Director | M Exercise | 1,447 | Not measured | Not measured |
| Jul 1, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 8,375 | Not measured | Not measured |
| Jul 1, 2026 | Gheuens Sarah | Chief Medical Officer | S Sale | 4,007 | $37.56 | $150,503 |
| Jul 1, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 8,375 | Not measured | Not measured |
| Jun 18, 2026 | Gheuens Sarah | Chief Medical Officer | A Award | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Burns James William | Chief Legal Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Jones Cecilia | Chief Financial Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Jones Cecilia | Chief Financial Officer | A Award | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Burns James William | Chief Legal Officer | A Award | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Foster-Cheek Kaye I | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Ho Maykin | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Owen Adams Catherine | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Ho Maykin | Director | A Award | 2,927 | Not measured | Not measured |
| Jun 18, 2026 | Milanova Tsveta | Chief Commercial Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Milanova Tsveta | Chief Commercial Officer | A Award | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Smith Cynthia | Director | A Award | 14,950 | Not measured | Not measured |
| Jun 18, 2026 | Gheuens Sarah | Chief Medical Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | Smith Cynthia | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Scadden David | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Ho Maykin | Director | A Award | 14,950 | Not measured | Not measured |
| Jun 18, 2026 | Viswanadhan Krishnan | Chief Strategy and Operations | M Exercise | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | FOUSE JACQUALYN A | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Ho Maykin | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Goff Brian | Chief Executive Officer | M Exercise | 39,000 | Not measured | Not measured |
| Jun 18, 2026 | FOUSE JACQUALYN A | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Foster-Cheek Kaye I | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | CAPELLO JEFFREY D | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Ballal Rahul D. | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Owen Adams Catherine | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Scadden David | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Smith Cynthia | Director | A Award | 2,927 | Not measured | Not measured |
| Jun 18, 2026 | Scadden David | Director | A Award | 2,927 | Not measured | Not measured |
| Jun 18, 2026 | Scadden David | Director | A Award | 14,950 | Not measured | Not measured |
| Jun 18, 2026 | Owen Adams Catherine | Director | A Award | 2,927 | Not measured | Not measured |
| Jun 18, 2026 | Owen Adams Catherine | Director | A Award | 14,950 | Not measured | Not measured |
| Jun 18, 2026 | Smith Cynthia | Director | M Exercise | 2,816 | Not measured | Not measured |
| Jun 18, 2026 | Goff Brian | Chief Executive Officer | A Award | 39,000 | Not measured | Not measured |
| Jun 18, 2026 | Viswanadhan Krishnan | Chief Strategy and Operations | A Award | 3,000 | Not measured | Not measured |
| Jun 18, 2026 | FOUSE JACQUALYN A | Director | A Award | 2,927 | Not measured | Not measured |
The full Form 4 history is on the AGIO company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.